<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>Medications for opioid use disorder</title>
    <subTitle>for healthcare and addiction professionals, policymakers, patients, and families</subTitle>
  </titleInfo>
  <name type="corporate">
    <namePart>Center for Substance Abuse Treatment (U.S.)</namePart>
    <role>
      <roleTerm type="text">issuing body.</roleTerm>
    </role>
  </name>
  <name type="corporate">
    <namePart>Knowledge Application Program (U.S.)</namePart>
  </name>
  <typeOfResource>text</typeOfResource>
  <genre authority="marc">bibliography</genre>
  <genre authority="">Handbook.</genre>
  <genre authority="fast">Handbooks and manuals.</genre>
  <genre authority="lcgft">Handbooks and manuals.</genre>
  <originInfo>
    <place>
      <placeTerm type="code" authority="marccountry">mdu</placeTerm>
    </place>
    <dateIssued encoding="marc">2018</dateIssued>
    <edition>Updated 2020</edition>
    <issuance>monographic</issuance>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
  </language>
  <physicalDescription>
    <form authority="marcform">print</form>
    <extent>iii, approximately 322 pages : color illustrations ; 28 cm.</extent>
  </physicalDescription>
  <tableOfContents>Part 1: An introduction to medications for the treatment of opioid use disorder. The approach to OUD care -- Overview of medications for OUD -- Duration of treatment with OUD medication -- Treatment settings -- Challenges to expanding access to OUD medication -- Resources -- Notes -- Part 2: Addressing opioid use disorder in general medical settings. Scope of the Problem -- Screening -- Assessment -- Treatment planning or referral -- Resources -- Appendix -- Notes -- Part 3: Pharmacotherapy for opioid use disorder. Pharmacotherapy for opioid use disorder -- Overview of pharmacotherapy for opioid use disorder. Methadone -- Naltrexone -- Buprenorphine -- Medical management strategies for patients taking OUD medications in office-based settings -- Medical management of patients taking OUD medications in hospital settings -- PART 4: Partnering addiction treatment counselors with clients and healthcare professionals. Overview and context -- Quick guide to medications -- Counselor-prescriber communications -- Creation of a supportive counseling experience -- Other common counseling concerns -- Notes -- Part 5: Resources related to medications for opioid use disorder. General Resources -- Resources for counselors and peer providers -- Resources for clients and families -- Provider tools and sample forms -- Glossary of TIP terminology -- Notes</tableOfContents>
  <note>"Printed 2018"-- back cover.</note>
  <note>Includes bibliographical references.</note>
  <note>Prepared by the Knowledge Application Program (KAP) for the Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration (SAMHSA), U.S. Department of Health and Human Services (HHS) under contract number 270-14-0445</note>
  <subject authority="lcsh">
    <topic>Opioid abuse</topic>
    <topic>Treatment</topic>
    <geographic>United States</geographic>
    <topic>Handbooks, manuals, etc</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Opioid abuse</topic>
    <topic>Chemotherapy</topic>
    <geographic>United States</geographic>
    <topic>Handbooks, manuals, etc</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Opioids</topic>
    <topic>Overdose</topic>
    <topic>Treatment</topic>
    <geographic>United States</geographic>
    <topic>Handbooks, manuals, etc</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Drug addicts</topic>
    <topic>Rehabilitation</topic>
    <geographic>United States</geographic>
    <topic>Handbooks, manuals, etc</topic>
  </subject>
  <subject authority="mesh">
    <topic>Opioid-Related Disorders</topic>
    <topic>drug therapy</topic>
  </subject>
  <subject authority="mesh">
    <topic>Opiate Substitution Treatment</topic>
    <topic>methods</topic>
  </subject>
  <subject authority="mesh">
    <topic>Narcotic Antagonists</topic>
    <topic>therapeutic use</topic>
  </subject>
  <subject authority="mesh">
    <topic>Buprenorphine</topic>
    <topic>therapeutic use</topic>
  </subject>
  <subject authority="mesh">
    <topic>Naltrexone</topic>
    <topic>therapeutic use</topic>
  </subject>
  <subject authority="mesh">
    <topic>Methadone</topic>
    <topic>therapeutic use</topic>
  </subject>
  <subject authority="fast">
    <topic>Drug addicts</topic>
    <topic>Rehabilitation</topic>
  </subject>
  <subject authority="fast">
    <topic>Opioid abuse</topic>
    <topic>Chemotherapy</topic>
  </subject>
  <subject authority="fast">
    <topic>Opioid abuse</topic>
    <topic>Treatment</topic>
  </subject>
  <subject authority="mesh">
    <geographic>United States</geographic>
  </subject>
  <subject authority="fast">
    <geographic>United States</geographic>
  </subject>
  <classification authority="lcc">RC568.O45 M49 2018</classification>
  <classification authority="ddc" edition="23">362.29/30973</classification>
  <classification authority="">HE 20.418:63</classification>
  <relatedItem type="series">
    <titleInfo>
      <title>Treatment improvement protocol (TIP) series ; 63</title>
    </titleInfo>
  </relatedItem>
  <relatedItem type="series">
    <titleInfo>
      <title>DHHS publication ; no. (SMA) 18-5063FULLDOC</title>
    </titleInfo>
  </relatedItem>
  <identifier type="lccn">2019410152</identifier>
  <identifier type="uri">https://purl.fdlp.gov/GPO/gpo107338</identifier>
  <identifier type="uri">https://store.samhsa.gov/shin/content/SMA18-5063FULLDOC/SMA18-5063FULLDOC.pdf</identifier>
  <location>
    <url displayLabel="Available in PDF, Mobi and epub versions">https://purl.fdlp.gov/GPO/gpo107338</url>
  </location>
  <location>
    <url displayLabel="PDF version">https://store.samhsa.gov/shin/content/SMA18-5063FULLDOC/SMA18-5063FULLDOC.pdf</url>
  </location>
  <recordInfo>
    <recordContentSource authority="marcorg">Z84</recordContentSource>
    <recordCreationDate encoding="marc">190709</recordCreationDate>
    <recordChangeDate encoding="iso8601">20250304151959.0</recordChangeDate>
    <recordIdentifier source="PUCPR">21065234</recordIdentifier>
    <languageOfCataloging>
      <languageTerm authority="iso639-2b" type="code">spa</languageTerm>
    </languageOfCataloging>
  </recordInfo>
</mods>
